PHGE (biomx.com) Net earnings per share (EPS TTM)

biomx.com (PHGE) - corporate logo

The rolling annual earnings per share of BiomX Inc. reflects a trend where the metric has reached the level of -217.47. BiomX Inc. robotic systems are accelerating bacteriophage discovery by replacing manual analysis. Drug production has been delegated to external CDMO facilities to minimize technical risks. However, the absence of commercial products leaves the business dependent on grants and legacy investments, as operating cash flow has not yet been established.

PHGE (BiomX Ltd) Net earnings per one share for the last twelve months history from 07/04/2022 to 09/11/2026

BiomX Inc (PHGE) - metric breakdowns and financial figures

- current quotes and average value forecast:
Price Chart BiomX Ltd|PHGE - Broker Consensus Forecast
- business market valuation indicators:
Market Capitalization BiomX Inc.|PHGE - Full Business Value
- business book valuation details:
Book Value per Share BiomX|PHGE - Total Stockholders' Equity|Market Capitalization to Book Value Ratio biomx.com|PHGE - Cumulative Company Assets
- debt and solvency information:
Total Debt to Equity Ratio BiomX Inc.|PHGE - Long-Term Loans to Capital Ratio|Short-Term Debt to Capital BiomX Ltd|PHGE - Company Total Debt Obligations|Debt to Book Capitalization Ratio BiomX Inc.|PHGE - Long-Term Debt|Company Short-Term Debt BiomX|Quick Liquidity biomx.com
- net income and valuation multiples indicators:
PHGE - Net Financial Result|Projected Future Earnings BiomX Inc.|PHGE - Price to Earnings Ratio|Forward P/E Multiple BiomX Ltd|PHGE - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization BiomX Inc.|PHGE - Profit before interest, taxes and amortization|Earnings per share for the last twelve months BiomX|PHGE - Net earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months biomx.com|PHGE - Earnings per share growth this year|Expected earnings per share growth for next year BiomX Inc.
- revenue and sales proceeds data:
PHGE - Company Sales Revenue|Projected Sales Volume BiomX Ltd|PHGE - Price-to-Revenue Coefficient|Price-to-Projected Revenue Ratio BiomX Inc.
Fundamental company analysis:PHGE - biomx.com
Flagship merchandise of BiomX Inc

Investors in BiomX Inc. (PHGE) must reconcile the company's market value with its actual performance. This metric measures the aggregate net income over a trailing twelve-month period distributed per share. By analyzing the trend of the fundamental TTM earnings per share, investors can filter out short-term reporting volatility. For a bacteriophage developer facing deficient hospital demand, this metric reflects the pace of the transition toward monetization. Negative or increasing values here determine the investment payback horizon.

Main competitors

SMMT - Earnings per share for the last twelve months|MRNA (modernatx.com) - Earnings per share for the last 12 months|PCVX: Net earnings per share (EPS TTM)|Earnings per one share for the last 12 months TARS (Tarsus Pharmaceuticals Inc)|CRMD (CorMedix Corp) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Seres Therapeutics, Inc MCRB|Net earnings per share (EPS TTM) SPRO|Net earnings per share for the last 12 months scynexis.com SCYX|AN2 Therapeutics - Net earnings per share for the last 12 months|Earnings per share for the last four quarters PYPD (PolyPid Ltd)|YS Biopharma - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Iterum Therapeutics plc ITRM|soligenix.com (SNGX) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months 60 Degrees Pharmaceuticals, Inc. (SXTP)|Earnings per share for the last twelve months Oragenics|Earnings per share for the last 12 months OPGN (OpGen Inc)